As the communications strategist for Ancora Pharmaceuticals, Crawford Strategies garners earned media to attract funding that supports the ground-breaking research and developments of the company. Using its patented, world-leading carbohydrate synthesis technology, Ancora is developing several promising synthetic carbohydrate-based vaccines to prevent some of today’s most infectious diseases such as malaria and staphylococcus aureus.